This finding was supported via independent differential gene expression analysis, indicating that LumB tumors, a more aggressive molecular subtype of breast cancer, were associated with statistically significant, higher mRNA levels of RACGAP1 than LumA tumors. The gene discussed is RACGAP1; the disease is breast carcinoma.